Racial/ethnic differences in BRCA1/2 and multigene panel testing among young breast cancer patients

被引：0
|
作者：
Trivedi, M. S.
Jones, T.
Jiang, X.
Underhill, M. L.
Bose, S.
Silverman, T.
Chung, W. K.
Kukafka, R.
Crew, K. D.
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Florida Atlantic Univ, Christine E Lynn Coll Nursing, Boca Raton, FL 33431 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-09-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-01
引用
收藏
页数：2
相关论文
共 50 条
  • [41] BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
    Matsuda, MLD
    Liede, A
    Kwan, E
    Mapua, CA
    Cutiongco, EMC
    Borg, ATÅ
    Narod, SA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (04) : 596 - 603
  • [42] NGS panel testing of negative BRCA1/2 index patients with Triple-Negative Breast Cancer in Cyprus
    Zanti, M.
    Loizidou, M. A.
    Michailidou, K.
    Pirpa, P.
    Machattou, C.
    Markou, Y.
    Kyriakou, F.
    Kakouri, E.
    Spyrou, G. M.
    Kyriacou, K.
    Hadjisavvas, A.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1602 - 1603
  • [43] Germline BRCA1 and BRCA2 testing for breast cancer survivors
    Wiggins, Jennifer
    McLoughlin, Anne
    George, Angela
    Ring, Alistair
    Kemp, Zoe
    [J]. JOURNAL OF MEDICAL GENETICS, 2020, 57 (08) : 528 - 530
  • [44] Patterns, predictors and prevalence of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
    Abdel-Razeq, Hikmat
    Abujamous, Lama
    Abunasser, Mahmoud
    Edaily, Sarah
    Bater, Rayan
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [45] Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients
    Schwartz, MD
    Lerman, C
    Brogan, B
    Peshkin, BN
    Isaacs, C
    DeMarco, T
    Halbert, CH
    Pennanen, M
    Finch, C
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 1003 - 1007
  • [46] Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients
    Schwartz, MD
    Lerman, C
    Brogan, B
    Peshkin, BN
    Halbert, CH
    DeMarco, T
    Lawrence, W
    Main, D
    Finch, C
    Magnant, C
    Pennanen, M
    Tsangaris, T
    Willey, S
    Isaacs, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1823 - 1829
  • [47] Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
    Evans, D. Gareth
    van Veen, Elke M.
    Woodward, Emma R.
    Harkness, Elaine F.
    Ellingford, Jamie M.
    Bowers, Naomi L.
    Wallace, Andrew J.
    Howell, Sacha J.
    Howell, Anthony
    Lalloo, Fiona
    Newman, William G.
    Smith, Miriam J.
    [J]. CANCERS, 2021, 13 (16)
  • [48] BRCA1 and BRCA2 in Indian Breast Cancer Patients
    Saxena, Sunita
    Szabo, Csilla I.
    Chopin, Sandrine
    Barjhoux, Laure
    Sinilnikova, Olga
    Lenoir, Gilbert
    Goldgar, David E.
    Bhatanager, Dinesh
    [J]. HUMAN MUTATION, 2002, 20 (06) : 473 - 474
  • [49] Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences
    Makhnoon, Sukh
    Gutierrez Barrera, Angelica M.
    Bassett, Roland
    Afrough, Aimaz
    Bedrosian, Isabelle
    Arun, Banu K.
    [J]. BREAST JOURNAL, 2022, 2022
  • [50] BRCA1/BRCA2 (BRCA) testing in young women with breast cancer: patterns; motivations and implications for treatment decisions
    Rosenberg, S.
    Ruddy, K.
    Tamimi, R.
    Gelber, S.
    Schapira, L.
    Come, S.
    Borges, V.
    Larsen, B.
    Garber, J.
    Partridge, A.
    [J]. BREAST, 2014, 23 : S8 - S8
12345